{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:15:10Z","timestamp":1772795710399,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier","isbn-type":[{"value":"9780081027509","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"WHO"},{"name":"MDA"},{"name":"ICH"},{"name":"Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.apar.2018.09.002","type":"book-chapter","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:28:48Z","timestamp":1540204128000},"page":"75-89","source":"Crossref","is-referenced-by-count":12,"title":["Challenges and Lessons From Conducting A Paediatric Clinical Trial in Sub-Saharan Africa: The Case of the Praziquantel Oral Dispersible Tablets Phase II Study in C\u00f4te d\u2019Ivoire"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apar.2018.09.002_bib1","series-title":"Overview of the Evidence for Safety and Efficacy of Medicines for the Treatment of Neglected Tropical Diseases in Children. Geneva","author":"Al-Saffer","year":"2010"},{"key":"10.1016\/bs.apar.2018.09.002_bib2","unstructured":"Anon The Process of Obtaining Informed Consent World Health Organization Research Ethics Review Committee."},{"key":"10.1016\/bs.apar.2018.09.002_bib3","series-title":"Best Pharmaceuticals for Children Act, Title IV (Public Law 107-109)","author":"Anon","year":"2002"},{"key":"10.1016\/bs.apar.2018.09.002_bib4","first-page":"1","article-title":"Regulation (EC) no 1901\/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending the regulation (EEC) No 1768\/92, Directive 2001\/20\/EC, Directive 2001\/83\/EC and regulation (EC) No 726\/2004","volume":"L378","author":"Anon","year":"2006","journal-title":"Official J Eur Union"},{"key":"10.1016\/bs.apar.2018.09.002_bib5","series-title":"Pediatric Research Equity Act, Title V (Public Law 110-85)","author":"Anon","year":"2007"},{"key":"10.1016\/bs.apar.2018.09.002_bib6","series-title":"Every Child\u2019s Birthright; Inequities and Trends in Birth Registration","author":"Anon","year":"2013"},{"key":"10.1016\/bs.apar.2018.09.002_bib7","series-title":"Potential and Principles for Health Sector Actions to Strengthen Civil Registration and Vital Statistics Systems","author":"Anon","year":"2013"},{"key":"10.1016\/bs.apar.2018.09.002_bib8","series-title":"Transforming Our World: The 2030 Agenda for Sustainable Development","author":"Anon","year":"2015"},{"key":"10.1016\/bs.apar.2018.09.002_bib9","series-title":"International Ethical Guidelines for Health-related Research Involving Humans","author":"Anon","year":"2016"},{"key":"10.1016\/bs.apar.2018.09.002_bib10","series-title":"Reflection Paper on Extrapolation of Efficacy and Safety in Paediatric Medicine Development","author":"Anon","year":"2016"},{"key":"10.1016\/bs.apar.2018.09.002_bib11","series-title":"Modification de la d\u00e9cision n\u00b01132 du 19 avril 2017 instituant des redevances pour les demandes d'Autorisation d'essais cliniques) publi\u00e9e le 2 Janvier 2018","author":"Anon","year":"2018"},{"key":"10.1016\/bs.apar.2018.09.002_bib12","series-title":"Pediatric Praziquantel Corsortium","author":"Anon","year":"2018"},{"key":"10.1016\/bs.apar.2018.09.002_bib13","series-title":"Schistosomiasis","author":"Anon","year":"2018"},{"key":"10.1016\/bs.apar.2018.09.002_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4269\/ajtmh.15-0530","article-title":"Sustaining the control of Schistosoma mansoni in western Cote d'Ivoire: baseline findings before the implementation of a randomized trial","volume":"94","author":"Assare","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/bs.apar.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/474569a","article-title":"Research in a war zone","volume":"474","author":"Bonfoh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.apar.2018.09.002_bib16","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1016\/S2214-109X(17)30187-0","article-title":"Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial","volume":"5","author":"Coulibaly","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/bs.apar.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-018-1066-y","article-title":"Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial","volume":"16","author":"Coulibaly","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/bs.apar.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.13-0630","article-title":"Doctors and vampires in sub-Saharan Africa: ethical challenges in clinical trial research","volume":"91","author":"Grietens","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/bs.apar.2018.09.002_bib19","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2800","article-title":"Stakeholder views of clinical trials in low- and middle-income countries: a systematic review","volume":"137","author":"Joseph","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/bs.apar.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1745-6215-12-145","article-title":"The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial","volume":"12","author":"Mbuagbaw","year":"2011","journal-title":"Trials"},{"key":"10.1016\/bs.apar.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S2214-109X(16)00009-7","article-title":"Reaching millennium development goal 4","volume":"4","author":"Molyneux","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/bs.apar.2018.09.002_bib22","first-page":"383","article-title":"Medicines regulation in Africa: current state and opportunities","volume":"31","author":"Ndomondo-Sigonda","year":"2017","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/bs.apar.2018.09.002_bib23","article-title":"The importance of blood is infinite: conceptions of blood as life force, rumours and fear of trial participation in a Fulani village in rural Gambia","volume":"11","author":"O'neill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.apar.2018.09.002_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000122","article-title":"It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North\u2013South collaborative trials","volume":"1","author":"Ravinetto","year":"2016","journal-title":"BMJ Global Health"}],"container-title":["Advances in Parasitology","Highlighting Operational and Implementation Research for Control of Helminthiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065308X18300587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065308X18300587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:04:01Z","timestamp":1758744241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065308X18300587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780081027509"],"references-count":24,"URL":"https:\/\/doi.org\/10.1016\/bs.apar.2018.09.002","relation":{},"ISSN":["0065-308X"],"issn-type":[{"value":"0065-308X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}